ATC code L02

ATC code L02 Endocrine therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup L02 is part of the anatomical group L Antineoplastic and immunomodulating agents.^[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QL02...^[2]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

L02A Hormones and related agents

L02AA Estrogens

L02AA01 Diethylstilbestrol

L02AA02 Polyestradiol phosphate

L02AA03 Ethinylestradiol

L02AA04 Fosfestrol

L02AB Progestogens

L02AB01 Megestrol

L02AB02 Medroxyprogesterone

L02AB03 Gestonorone

L02AE Gonadotropin-releasing hormone analogues

L02AE01 Buserelin

L02AE02 Leuprorelin

L02AE03 Goserelin

L02AE04 Triptorelin

L02AX Other hormones

L02B Hormone antagonists and related agents

L02BA Anti-estrogens

L02BA01 Tamoxifen

L02BA02 Toremifene

L02BA03 Fulvestrant

L02BB Anti-androgens

L02BB01 Flutamide

L02BB02 Nilutamide

L02BB03 Bicalutamide

L02BG Aromatase inhibitors

L02BG01 Aminogluthetimide

L02BG02 Formestane

L02BG03 Anastrozole

L02BG04 Letrozole

L02BG05 Vorozole

L02BG06 Exemestane

L02BX Other hormone antagonists and related agents

L02BX01 Abarelix

L02BX02 Degarelix

L02BX03 Abiraterone

References